Eam Global Investors LLC Kura Oncology, Inc. Transaction History

Eam Global Investors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$24.75 - $39.14 $2.03 Million - $3.22 Million	-82,159 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$29.0 - $41.62 $1.44 Million - $2.06 Million	-49,597 Reduced 37.64%	82,159 $2.68 Million
Q3 2020 Nov 13, 2020	BUY	$16.3 - $30.64 $2.15 Million - $4.04 Million	131,756 New	131,756 $4.04 Million
Q2 2018 Aug 03, 2018	SELL	$14.8 - $18.8 $782,698 - $994,238	-52,885 Closed	0 $0
Q1 2018 Jun 04, 2018	SELL	$14.5 - $23.4 $339,517 - $547,911	-23,415 Reduced 30.69%	52,885 $992,000
Q4 2017 Jun 04, 2018	BUY	$13.5 - $16.65 $1.03 Million - $1.27 Million	76,300	76,300 $1.17 Million

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $598M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Global Investors LLC with notifications on news.